HRTX vs RCL · rev $72.4M vs P/E 26, rev $9.28B
Heron Therapeuti (HRTX) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
HRTX currently screens at market cap $332.6M. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the HRTX and RCL stock pages for the full models.
Not investment advice.